Ocular Melanoma — Trials

Ocular Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 6
Growth YoY: —
Industry share: 35%
Top sponsor: IDEAYA Biosciences
Termination share: 31.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (36)

clinicaltrialsPublishedShowing 101–121 of 121 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00089206	Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery	completed	Phase 2	7	University of VirginiaOTHER	1	Dec 19, 2014	clinicaltrials
NCT01377025	A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma(STREAM)	unknown	Phase 2	200	Prof. Dr. med. Max. E. ScheulenOTHER	1	Dec 3, 2014	clinicaltrials